Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Fullerenes show potential in skin care but need more safety research.

Eating the right nutrients can improve hair health, but taking extra supplements usually doesn't help unless you have a deficiency.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

An imbalanced gut and lack of biotin can cause hair loss in mice.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Long-term parenteral nutrition without zinc can cause severe zinc deficiency.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Skin problems are very common in people with end-stage kidney disease.

Inactive hair follicle stem cells help prevent skin cancer.

Notch-related genes play a key role in the development and cycling of hair follicles.

Fat from the body can help improve hair growth and scars when used in skin treatments.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Apoptosis is crucial for healthy skin and treating skin diseases.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Hydrogels could lead to better treatments for wound healing without scars.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.